Cure Nutraceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Cure Nutraceutical
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abidhussain Aglodiya, Sajidbhai Kadiwal, Aamirbhai Kadiwal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100GJ2014PTC078441
- Company No.
078441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Patan, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cure Nutraceutical Private Limited offer?
Cure Nutraceutical Private Limited offers a wide range of products and services, including Fitness Supplements, Colostrum Powder, Nutraceuticals & Dietary Supplements, Colostrum Capsule, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Dietary Supplements.
Who are the key members and board of directors at Cure Nutraceutical?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abidhussain Aglodiya  | Director | 27-Jan-2014 | Current |
| Sajidbhai Kadiwal | Director | 27-Jan-2014 | Current |
| Aamirbhai Kadiwal | Director | 05-Feb-2014 | Current |
| Imtiyazali Aglodiya | Director | 05-Feb-2014 | Current |
| Hasanali Aglodiya | Director | 05-Feb-2014 | Current |
| Shahidbhai Kadival | Director | 27-Jan-2014 | Current |
Financial Performance of Cure Nutraceutical.
Cure Nutraceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cure Nutraceutical?
In 2017, Cure Nutraceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cure Nutraceutical?
Unlock and access historical data on people associated with Cure Nutraceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Nutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Nutraceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
